CoChat

A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study

Open access

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

BACKGROUND: In a previous pilot study, adrenal suppression was found to be common after antiemetic dexamethasone therapy in cancer patients. The objective of this large prospective multicenter study was to confirm the incidence and factors associated with secondary adrenal suppression related to antiemetic dexamethasone therapy in cancer patients receiving chemotherapy. METHODS: Chemotherapy-naïve patients who were scheduled to receive at least three cycles of highly or moderately emetogenic chemotherapy with dexamethasone as an antiemetic were enrolled. Patients with a suppressed adrenal response before chemotherapy or those administered corticosteroids within 6 months of enrollment in the study were excluded. RESULTS: Between October 2010 and August 2014, 481 patients receiving chemotherapy underwent the rapid adrenocorticotropic hormone (ACTH) stimulation test to assess eligibility; 350 of these patients were included in the final analysis. Fifty-six patients (16.0%) showed a suppressed adrenal response in the rapid ACTH stimulation test at 3 or 6 months after the start of the first chemotherapy. The incidence of adrenal suppression was affected by age, performance status, stage, and use of megestrol acetate in univariate analysis. Multivariate analysis revealed that secondary adrenal suppression associated with antiemetic dexamethasone therapy was significantly associated with megestrol acetate treatment (odds ratio: 3.06; 95% confidence interval: 1.60 to 5.86; p < .001). CONCLUSION: This large prospective study indicates that approximately 15% of cancer patients receiving chemotherapy with a normal adrenal response show suppressed adrenal responses after antiemetic dexamethasone therapy. This result was particularly significant for patients cotreated with megestrol acetate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1634/theoncologist.2015-0211

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 1

  1. 2015, NCCN Clinical Practice Guidelines in Oncology. Antiemesis, version 2, 2014

Cited by

See all 34

Metadata

Authors
Han, H. S., Park, J. C., Park, S. Y., Lee, K. T., Bae, S. B., Kim, H. J., Kim, S., Yun, H. J., Bae, W. K., Shim, H.-J., Hwang, J.-E., Cho, S.-H., Park, M.-R., Shim, H., Kwon, J., Choi, M. K., Kim, S. T., & Lee, K. H.
Affiliations
  • Chungbuk National University (KR)
  • The Catholic University of Korea Daejeon St. Mary's Hospital (KR)
  • Soonchunhyang University (KR)
  • Chungnam National University (KR)
  • Chonnam National University (KR)
  • Wonkwang University (KR)
Corresponding author
Lee, Ki Hyeong
Venue
The Oncologist
Published
2015-10-13
Volume
20
Issue
12
Pages
1432-1439
ISSN
  • 1083-7159 (ISSN-L)
  • 1549-490X
OpenAlex
W2215816454
Cited by
34
References
32
Citations by year
2026: 3 · 2024: 8 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 1
FWCI
2.02
Type
journal article
Language
en
Open access
Locations
  • The Oncologist (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
dexamethasone, antiemetic therapy, chemotherapy-induced nausea and vomiting, megestrol acetate, ACTH stimulation test, emetogenic chemotherapy, cancer patients, risk factors
MeSH terms
Adrenal Insufficiency, Adult, Aged, Aged, 80 and over, Antiemetics, Antineoplastic Combined Chemotherapy Protocols, Dexamethasone, Female, Humans, Hydrocortisone, Male, Middle Aged, Neoplasms, Prednisolone, Prospective Studies, Treatment Outcome, Megestrol Acetate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study. https://app.cochat.ai/papers/10.1634/theoncologist.2015-0211
The paper
Han, H. S., Park, J. C., Park, S. Y., Lee, K. T., Bae, S. B., Kim, H. J., Kim, S., Yun, H. J., Bae, W. K., Shim, H.-J., Hwang, J.-E., Cho, S.-H., Park, M.-R., Shim, H., Kwon, J., Choi, M. K., Kim, S. T., & Lee, K. H. (2015). A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study. The Oncologist. https://doi.org/10.1634/theoncologist.2015-0211

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.